AstraZeneca: Covid-19 Vaccine Is 92% Effective Against Indian Variant
15 Juni 2021 - 8:35AM
Dow Jones News
By Ian Walker
AstraZeneca PLC said Tuesday that its Covid-19 vaccine is 92%
effective against hospitalizations of the Delta, or Indian, variant
after two shots, without any deaths.
The pharmaceutical giant also said the vaccine is 86% effective
in reducing hospitalizations in the Alpha, or Kent, variant with no
deaths reported.
Vaccine effectiveness against symptomatic disease was 74%
against the Alpha variant and 64% against the Delta variant,
AstraZeneca added.
"The data show that the vaccine will continue to have a
significant impact around the world given that it continues to
account for the overwhelming majority of supplies to India and the
Covax facility," Executive Vice President, BioPharmaceuticals
R&D Mene Pangalos said.
Write to Ian Walker at ian.walker@wsj.com
(END) Dow Jones Newswires
June 15, 2021 02:35 ET (06:35 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
